
Avey
A clinical AI trio of products powered by a medicine-native LLM

Tool details
Avey started in Qatar and turned its in-house medical LLM Olive into three products: personal Q&A Avey Chat, a developer API, and a hospital enterprise suite, AI C-Suite, connecting consultations and charting all the way through to coding and claims.
Core capabilities
- Avey Chat: free sign-up; answers everyday medical questions such as interpreting lab reports and medication dosages
- Olive API: OpenAI-compatible; migrate by changing base_url and key; 65,536-token context
- The Collaborator: transcribes consultations, reads history from the EMR, and outputs differential diagnoses with reasoning
- The Cowriter: generates structured notes and validates drug interactions and dosages
- The Coder: automatically codes ICD/CPT/NDC and generates payer-compliant claims
- Open foundation: an attention-free architecture with an arXiv paper and open weights
Where it fits An individual checking which department to visit for a symptom, a developer who wants a clinical LLM to trial quickly, an organization that wants to cut the documentation and coding burden on doctors: it handles all of these. The reverse: scenarios that require traceable clinical decisions or FDA clearance backing are not worth considering for now.
Distinct advantages Most peers cover only one segment: Abridge does documentation, Ada does triage. Avey is one of the few that does architecture, its own benchmarks, an app and an enterprise suite all in one pass, and it connects with nothing more than a base_url change.
Editorial verdict The technology is real: papers, Apache-2.0 weights and a 208×H200 training record you can check, plus solid documentation. But the compliance and commercial evidence is glaringly thin: the HIPAA page carries only a single self-description plus Last audit: June 2025, with no BAA, while the API documentation plainly says "do not send protected health information", and the whole site never mentions FDA, 510(k) or SaMD. The flagship vignette scores come from a 2021 test of the old Bayesian engine, the comparison group had no GPT-4o or Med-PaLM, all authors are employees and the first author is the CEO; the ICD benchmark never evaluated Avey's own model. Zero G2 reviews, no customer cases, no public pricing. Verdict: worth tracking, but ask for a BAA and a quote before purchasing.
Pricing
Freemium$0 (Avey Chat free tier)Avey AI C-Suite Standard offers a free trial (the site's 'Try for free'), and you can start without a published quoteFree sign-up for individuals and clinicians, used directly in the browser, with no paid tier
The site's button reads Try for free; trial length and quota are not published
Everything in the Standard plan plus custom capabilities and dedicated customer support
OpenAI-compatible endpoint, charged per token against a prepaid credit balance
Additional notes
The site has no standalone /pricing page; the product's 'Plans & pricing' is only an in-page anchor; both Enterprise and the enterprise API are quote-based or prepaid, with no published numeric unit price.
FAQ
User reviews
User Reviews
No reviews yet
No one has reviewed this tool yet